List | Section | Observation |
---|---|---|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 15.1.7 Anticholinesterases |
Others observations: methylsulphate |
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 12:04 Cholinergic Agents | No observations |
Barbados. Barbados National Drug Formulary (BNDF) | 12.04 Parasympathetic (Cholinergic) Agents | No observations |
Belize. National Drug Formulary | 01.04 Muscle relaxants and cholinesterase inhibitors | No observations |
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 10.02.01 Drugs that enhance neuromuscular transmission (Anticholinesterases) | No observations |
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 15.01.06 Anticholinesterases Used in Surgery | No observations |
List | Section | Observation |
---|---|---|
Bahamas. Drug Formulary | 06.04. Anaesthetic Adjuncts and Adjuvants | No observations |
List | Section | Observation |
---|---|---|
Guyana. Essential Medicines List. 2020-2021 | 2.01. Cholinesterase inhibitors | No observations |
List | Section | Observation |
---|---|---|
Peru | 20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants | No observations |
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. | No observations |
Suriname. NGK-C-011 | 20. Muscle Relaxants and Cholinesterase Inhibitors | No observations |
Haiti. National List of Essential Medicines | 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS | No observations |
Ecuador | Essential Medicines List - Ecuador | No observations |
Belize. National Drug Formulary | 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS | No observations |
Belize. National Drug Formulary | 01.04 Muscle relaxants and cholinesterase inhibitors | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS | No observations |
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Autonomic Cholinergic | No observations |
Haiti. National List of Essential Medicines | 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors | No observations |
Bahamas. Drug Formulary | 20.1 Cholinergic and Anticholinesterase Agents | No observations |
Bahamas. Drug Formulary | 06.04. Anaesthetic Adjuncts and Adjuvants | No observations |
Belize. National Drug Formulary | 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS | No observations |
List | Section | Observation |
---|---|---|
Costa Rica. Caja Costarricense de Seguro Social. 2019 | 22. Colinérgicos |
Others observations: Como metilsulfato. |
Mexico. Cuadro Basico de Medicamentos - 2017 | 02. ANESTESIA | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 11. INTOXICACIONES | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 02. ANESTESIA | No observations |
Paraguay. Lista de Medicamentos Esenciales. 2009 | 07. OTRAS DROGAS QUE ACTÚAN SOBRE EL SISTEMA NERVIOSO | No observations |
El Salvador - 2019 | Otras DROGAS QUE AFECTAN EL SISTEMA NERVIOSO | No observations |
Chile. Formulario Nacional de Medicamentos. 2005 | 01.04. RELAJANTES MUSCULARES | No observations |
Chile. Formulario Nacional de Medicamentos. 2005 | 16.07. OTROS | No observations |
Bahamas. Drug Formulary | 20.1 Cholinergic and Anticholinesterase Agents | No observations |
List | Section | Observation |
---|---|---|
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: metilsulphate INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 17.02. ANTICOLINESTERÁSICOS Y FÁRMACOS PARA DIAGNÓSTICO Y TRATAMIENTO DE LA MIASTENIA GRAVIS | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS | No observations |
Peru | 20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants | No observations |
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: EST. X 2 BLISTER X 10 TABLETAS C/U. |
Costa Rica. Caja Costarricense de Seguro Social. 2019 | 22. Colinérgicos | No observations |
Mexico. Cuadro Basico de Medicamentos - 2017 | 02. ANESTESIA | No observations |
Chile. Formulario Nacional de Medicamentos. 2005 | 16.07. OTROS | No observations |
Haiti. National List of Essential Medicines | 20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors | No observations |
Barbados. Barbados National Drug Formulary (BNDF) | 12.04 Parasympathetic (Cholinergic) Agents | No observations |
Bahamas. Drug Formulary | 20.1 Cholinergic and Anticholinesterase Agents | No observations |
Belize. National Drug Formulary | 20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS | No observations |